Cargando…

Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis

Treatment of multidrug-resistant tuberculosis (MDR-TB) is challenging because of the high toxicity of second-line drugs and the longer treatment duration required compared with drug-susceptible TB. The efficacy of treatment for MDR-TB is poorer than that for drug-susceptible TB. The selection of dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Tae Sun, Jo, Kyung-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902820/ https://www.ncbi.nlm.nih.gov/pubmed/24475350 http://dx.doi.org/10.3947/ic.2013.45.4.367

Ejemplares similares

Sequelae of pulmonary multidrug-resistant tuberculosis at the completion of treatment
por: Singla, Rupak, et al.
Publicado: (2018)

Prevalence of Latent Tuberculosis Infection among Medical Students in South Korea
por: Jung, Da Ho, et al.
Publicado: (2012)

Diagnosis and treatment of multidrug-resistant tuberculosis
por: Jang, Jong Geol, et al.
Publicado: (2020)

Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
por: Jeon, Doosoo, et al.
Publicado: (2020)

Profile of delamanid for the treatment of multidrug-resistant tuberculosis
por: Szumowski, John D, et al.
Publicado: (2015)

Diagnostic yield of post-bronchoscopy sputum for diagnosing pauci-bacillary pulmonary tuberculosis
por: Park, Joung Ha, et al.
Publicado: (2021)

Changes in chest X-ray findings in 1- and 2-month group after treatment initiation for suspected pulmonary tuberculosis
por: Lee, Jang Ho, et al.
Publicado: (2020)

Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea
por: Kang, Bo Hyoung, et al.
Publicado: (2017)

Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector
por: Jeon, Doo Soo, et al.
Publicado: (2011)

Six-month Therapy with Aerosolized Interferon-γ for Refractory Multidrug-Resistant Pulmonary Tuberculosis
por: Koh, Won-Jung, et al.
Publicado: (2004)

Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series
por: Wang, Lin, et al.
Publicado: (2017)

Nomogram for individualized prediction of incident multidrug-resistant tuberculosis after completing pulmonary tuberculosis treatment
por: Cheng, Qinglin, et al.
Publicado: (2020)

Radiological Findings of Extensively Drug-Resistant Pulmonary Tuberculosis in Non-AIDS Adults: Comparisons with Findings of Multidrug-Resistant and Drug-Sensitive Tuberculosis
por: Cha, Jihoon, et al.
Publicado: (2009)

Successful Treatment with a High-dose Rifampin-containing Regimen for Pulmonary Tuberculosis with a Disputed rpoB Mutation
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

Current therapies for the treatment of multidrug-resistant tuberculosis in children in India
por: Mukherjee, Aparna, et al.
Publicado: (2017)

Prevalence of multidrug-resistant tuberculosis among Category II pulmonary tuberculosis patients
por: Sharma, Surendra K., et al.
Publicado: (2011)

Multidrug-resistant Pulmonary Tuberculosis Among Young Korean Soldiers in a Communal Setting
por: Lee, Sei Won, et al.
Publicado: (2009)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan
por: Lin, Chih-Bin, et al.
Publicado: (2019)

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
por: Bernard, Christine, et al.
Publicado: (2014)

Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis
por: Deshkar, Anuradha T, et al.
Publicado: (2022)

Treatment Outcomes Associated with Multidrug-resistant Tuberculosis
por: Gupta, Nitin, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
por: Moodley, Riya, et al.
Publicado: (2016)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
por: Pecora, Francesco, et al.
Publicado: (2021)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

Predictors of Treatment Success for Multidrug Resistant Tuberculosis
por: Park, Sang Won
Publicado: (2016)

Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis
por: Martínez, Dalila, et al.
Publicado: (2010)

Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China
por: Zhao, Jiang-nan, et al.
Publicado: (2015)

Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care
por: Biadglegne, Fantahun, et al.
Publicado: (2014)

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
por: Li, Yang, et al.
Publicado: (2018)

Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Patients with Pulmonary Tuberculosis in Zahedan, Southeastern Iran
por: Metanat, M, et al.
Publicado: (2012)

QuantiFERON-TB Gold PLUS versus QuantiFERON-TB Gold In-Tube test for diagnosing tuberculosis infection
por: Kim, Soo Han, et al.
Publicado: (2020)

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
por: Conradie, Francesca, et al.
Publicado: (2020)

Efficacy and effect of free treatment on multidrug-resistant tuberculosis
por: ZHANG, QING, et al.
Publicado: (2016)

Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multidrug-Resistant Tuberculosis
por: Wang, Xiaofeng, et al.
Publicado: (2020)

Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum-positive pulmonary tuberculosis
por: Sharma, Surendra K., et al.
Publicado: (2011)

Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia
por: Desissa, Fanta, et al.
Publicado: (2018)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_chu7q166h2te949me71nbj9dur